Appointment of m/s. Mohta khetawat & Co. Chartered Accountant as a Inetrnal Auditor and Kamlesh M. Shah & Co. Company Secretaries as a Secretarial Auditors for a period of Five years.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenith Healthcare's board met on 27th May 2025 and approved audited financial results for Q4 and FY ended 31st March 2025, with statutory auditor Doshi Doshi & Co. issuing an unmodified (clean) opinion. The board appointed M/s. Mohta Khetawat & Co. as Internal Auditor for FY 2025-26 and Kamlesh M. Shah & Co. as Secretarial Auditors for a 5-year term (FY26 to FY30). FY25 revenue from operations fell to ₹1,132.97 lakhs (vs ₹1,447.24 lakhs in FY24, a ~22% decline), while net profit dropped sharply to ₹6.70 lakhs (vs ₹20.35 lakhs), with EPS of ₹0.013. Q4 FY25 showed a turnaround to a net profit of ₹10.97 lakhs from a loss of ₹25.76 lakhs in Q4 FY24. Related party transactions were noted and authorized for FY26, and the MD was empowered to fix AGM dates.
FY25 results are weak with revenue and profit both declining sharply year-on-year, though Q4 turned profitable. For shareholders, the clean audit opinion and routine auditor appointments are neutral, but the steep drop in full-year earnings and lower operating cash flow (₹67.45 lakhs vs ₹173.62 lakhs) may weigh on sentiment.